Syndromic breast hypoplasia/aplasia

Syndromic breast hypoplasia/aplasia (Orphanet code 180193) is not a single disease but rather a clinical grouping that encompasses several rare genetic syndromes in which underdevelopment (hypoplasia) or complete absence (aplasia) of one or both breasts occurs as part of a broader constellation of congenital anomalies. This category includes conditions such as Poland syndrome, ulnar-mammary syndrome, limb-mammary syndrome, and other rare syndromic entities where breast maldevelopment is a defining feature alongside abnormalities in other organ systems. The body systems affected vary depending on the specific underlying syndrome but commonly include the musculoskeletal system (limb defects, chest wall anomalies, rib or pectoral muscle absence), the ectodermal structures (nipple anomalies, hair and nail changes, dental abnormalities, sweat gland dysfunction), and sometimes the genitourinary or endocrine systems. Breast hypoplasia or aplasia typically becomes clinically apparent during puberty when expected breast development fails to occur or is markedly asymmetric. In some syndromes, the condition is evident at birth due to associated chest wall or limb malformations. Treatment is largely supportive and symptomatic. Breast reconstruction or augmentation surgery may be offered for cosmetic and psychosocial reasons, typically after puberty. Management of associated anomalies (such as limb differences, cleft palate, or ectodermal features) requires a multidisciplinary approach involving orthopedics, plastic surgery, dermatology, and other specialists as needed. Genetic counseling is recommended for affected individuals and their families, as the inheritance pattern and recurrence risk depend on the specific syndrome diagnosed.

Common questions about Syndromic breast hypoplasia/aplasia